| Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution G Buccheri, D Ferrigno, M Tamburini European journal of cancer 32 (7), 1135-1141, 1996 | 718 | 1996 |
| Depressive reactions to lung cancer are common and often followed by a poor outcome G Buccheri European Respiratory Journal 11 (1), 173-178, 1998 | 305 | 1998 |
| CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients JL Pujol, O Molinier, W Ebert, JP Daures, F Barlesi, G Buccheri, ... British Journal of Cancer 90 (11), 2097-2105, 2004 | 260 | 2004 |
| Lung cancer: clinical presentation and specialist referral time G Buccheri, D Ferrigno European Respiratory Journal 24 (6), 898-904, 2004 | 234 | 2004 |
| Serum tumour markers in lung cancer: history, biology and clinical applications D Ferrigno, G Buccheri, A Biggi European Respiratory Journal 7 (1), 186-197, 1994 | 183 | 1994 |
| Prognostic factors in lung cancer: tables and comments G Buccheri, D Ferrigno European Respiratory Journal 7 (7), 1350-1364, 1994 | 177 | 1994 |
| Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC) D Ferrigno, G Buccheri, C Giordano Lung Cancer 41 (3), 311-320, 2003 | 145 | 2003 |
| Haemostatic abnormalities in lung cancer: prognostic implications G Buccheri, D Ferrigno, C Ginardi, C Zuliani European Journal of Cancer 33 (1), 50-55, 1997 | 141 | 1997 |
| Prognostic significance of blood coagulation tests in lung cancer D Ferrigno, G Buccheri, I Ricca European Respiratory Journal 17 (4), 667-673, 2001 | 138 | 2001 |
| The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer GF Buccheri, D Ferrigno, M Tamburini, C Brunelli Lung cancer 12 (1-2), 45-58, 1995 | 138 | 1995 |
| Plasma levels of D‐dimer in lung carcinoma: Clinical and prognostic significance G Buccheri, P Torchio, D Ferrigno Cancer 97 (12), 3044-3052, 2003 | 135 | 2003 |
| Diagnostic, morphologic, and histopathologic correlates in bronchogenic carcinoma: a review of 1,045 bronchoscopic examinations G Buccheri, P Barberis, MS Delfino Chest 99 (4), 809-814, 1991 | 128 | 1991 |
| Cranial computed tomography as a part of the initial staging procedures for patients with non-small-cell lung cancer D Ferrigno, G Buccheri Chest 106 (4), 1025-1029, 1994 | 127 | 1994 |
| Clinical equivalence of two cytokeratin markers in non-small cell lung cancer: a study of tissue polypeptide antigen and cytokeratin 19 fragments G Buccheri, P Torchio, D Ferrigno Chest 124 (2), 622-632, 2003 | 113 | 2003 |
| Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19‐9 GF Buccheri, D Ferrigno, AM Sartoris, B Violante, F Vola, A Curcio Cancer 60 (1), 42-50, 1987 | 111 | 1987 |
| Continuation of chemotherapy versus supportive care alone in patients with inoperable non‐small cell lung cancer and stable disease after two or three cycles of MACC. Results … GF Buccheri, D Ferrigno, A Curcio, F Vola, A Rosso Cancer 63 (3), 428-432, 1989 | 105 | 1989 |
| Clinical value of a multiple biomarker assay in patients with bronchogenic carcinoma GF Buccheri, B Violante, AM Sartoris, D Ferrigno, A Curcio, F Vola Cancer 57 (12), 2389-2396, 1986 | 103 | 1986 |
| Lung tumor markers of cytokeratin origin: an overview G Buccheri, D Ferrigno Lung Cancer 34, S65-S69, 2001 | 97 | 2001 |
| Usefulness of tissue polypeptide antigen in staging, monitoring, and prognosis of lung cancer G Buccheri, D Ferrigno Chest 93 (3), 565-570, 1988 | 78 | 1988 |
| Hematologic counts and clinical correlates in 1201 newly diagnosed lung cancer patients D Ferrigno, G Buccheri Monaldi archives for chest disease 59 (3), 193-198, 2003 | 75 | 2003 |
